Ann: PYC Expands US Executive Leadership Team, page-9

Sorry that the HC System has redacted the URL. Here I have reposted with the link as plain text. Please copy and paste into your browser.

@bigpharma I think you are talking about the flop of a different drug SR-9001 from Sarepta and the link to that article you mentioned is https://www.**promotion blocked**/investing/2021/01/10/heres-why-sarepta-therapeutics-lost-support-on-wal/

@SoT is absolutely correct in alerting us that Sarepta has just received FDA approval on 25.02.2021 for its AMONDYS 45 (Casimersen). Link to the FDA's official announcement is https://www.fda.gov/news-events/press-announcements/fda-approves-targeted-treatment-rare-duchenne-muscular-dystrophy-mutation-0